Graves Orbitopathy: Clinical Trials

1 trial for Graves Orbitopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1

Follow Graves Orbitopathy: new trials by email Literature Review of Graves Orbitopathy trials Research Report on Graves Orbitopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Atorvastatin and Its Effects in Clinical and Radiological Aspects in Patients With Moderate-to-Severe Thyroid Eye Disease
Atorvastatin, methylprednisolone (IVMP) - Thyroid Eye Disease, Graves Ophthalmopathy
Phase 1Not yet recruitingBanu Aji Dibyasakti642026-08-302026-08-13

Narrower conditions

Graves Ophthalmopathy (1)

Broader conditions

Autoimmune Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Endocrine System Diseases (1)  ·  Exophthalmos (1)  ·  Eye Diseases (1)  ·  Eye Diseases, Hereditary (1)  ·  Genetic Diseases, Inborn (1)  ·  Goiter (1)  ·  Graves Disease (1)  ·  Hyperthyroidism (1)  ·  Immune System Diseases (1)  ·  Orbital Diseases (1)  ·  Thyroid Diseases (1)

Interventions

Atorvastatin (1)  ·  Methylprednisolone (1)

Sponsors

Banu Aji Dibyasakti (1)

Countries

Indonesia (1)